TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $460 | -90.3% | 55 | -71.1% | 0.00% | – |
| Q2 2023 | $4,720 | +66.0% | 190 | +0.5% | 0.00% | – |
| Q1 2023 | $2,843 | -58.9% | 189 | -67.7% | 0.00% | – |
| Q4 2022 | $6,920 | -99.8% | 585 | -99.9% | 0.00% | -100.0% |
| Q3 2022 | $3,449,000 | -63.7% | 582,421 | -73.9% | 0.01% | -61.5% |
| Q2 2022 | $9,499,000 | +27.6% | 2,234,979 | +185.6% | 0.03% | +52.9% |
| Q1 2022 | $7,442,000 | +2218.4% | 782,533 | +12576.7% | 0.02% | +1600.0% |
| Q4 2020 | $321,000 | -71.2% | 6,173 | -85.2% | 0.00% | -66.7% |
| Q3 2020 | $1,115,000 | -85.6% | 41,652 | -89.5% | 0.00% | -84.2% |
| Q2 2020 | $7,753,000 | +746.4% | 398,008 | +327.7% | 0.02% | +533.3% |
| Q1 2020 | $916,000 | +45700.0% | 93,051 | +46425.5% | 0.00% | – |
| Q4 2019 | $2,000 | -99.8% | 200 | -99.7% | 0.00% | -100.0% |
| Q2 2018 | $982,000 | +20.2% | 74,643 | +29.7% | 0.00% | +50.0% |
| Q1 2018 | $817,000 | – | 57,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |